DOI: 10.25881/BPNMSC.2020.95.30.022

Authors

Tyurin V.P., Savchuk О.V., Proskurnova V.V., Dobrikov E.A., Kulagina A.M.

Pirogov National Medical and Surgical Center, Moscow

Abstract

Significant number of clinical trials demonstrate an increased risk of cardiovascular diseases and their complications in patients who suffer from insomnia or sleep-related breathing disturbances. Obstructive sleep apnea (OSA) is the most clinically significant disease of sleep-related breathing disturbances. We have analyzed a large amount of accumulated literature on this topic in recent years. Timely detection of sleep disorders, in particular OSA, as well as their treatment allows for timely prevention of cardiovascular mortality. This group of patients has an increased risk of early death, and therefore OSA requires active verification and treatment in routine clinical practice.

Keywords: obstructive sleep apnea, cardiovascular diseases, mortality.

References

1. Levin YaI, Kovrov GV, Poluektov MG, et al. Insomniya, sovremennye diagnosticheskie i lechebnye podkhody. Moscow: Medpraktika-M; 2005.

2. Kripke DF, Garfinkel L, Wingard DL, et al. Mortality associaced with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59(2):131–136. Doi: 10.1001/archpsyc.59.2.131.

3. Poluektov MG. Primary and secondary insomnias and sleep related breathing disturbances. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;111(9–2):10–18.

4. American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. Westchester: American Academy of Sleep Medicine; 2005.

5. Tsai JC. Neurological and neurobehavioral sequelae of obstructive sleep apnea. NeuroRehabilitation. 2010;26(1):85–94. Doi: 10.3233/NRE-2010-0538.

6. Volov NA, Shaydyuk OYu, Taratukhin EO. Sleep apnea syndrome and cardiovascular risk factors. Rossiiskii kardiologicheskii zhurnal. 2008;13(3):65–70.

7. Can M, Açikgöz S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest. 2006;129(2):233–237. Doi: 10.1378/chest.129.2.233.

8. Nieto FJ, Young ТВ, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283(14):1829–1836. Doi: 10.1001/jama.283.14.1829.9.

9. medscape.com [Internet]. Smith WM. Obstructive sleep apnea and home sleep monitoring overview of obstructive sleep apnea [cited 2020 Apr 15]. Available at: http://emedicine.medscape.com/article/1518830-overview.

10. Baguet JP, Barone-Rochette G, Lévy P, et al. Left ventricular diastolic dysfunction is linked to severity of obstructive sleep apnoea. Eur Respir J. 2010;36(6):1323–1329. Doi: 10.1183/09031936.00165709.11.

11. Lipford MC, Flemming KD, Calvin AD, et al. Associations between cardioembolic stroke and obstructive sleep apnea. Sleep. 2015;38(11):1699–1705. Doi: 10.5665/sleep.5146.

12. Rangemark C, Hedner JA, Carlson JT, et al. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep. 1995;18(3):188–194. Doi: 10.1093/sleep/18.3.188.

13. Buzunov RV, Legeida IV, Tsareva EV. Khrap i sindrom obstruktivnogo apnoe sna u vzroslykh i detei. Moscow: Barvikha; 2013. 123 p.

14. Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med. 2008;168(3):297-301. Doi: 10.1001/archinternmed.2007.70.

15. Kuznetsov AN, Vinogradov OI. Ishemicheskii insul't. Diagnostika, lechenie, profilaktika (karmannyi spravochnik). 3rd ed. Moscow: RAEN; 2014. P. 80–86.

16. Lavergne F, Morin L, Armitstead J, et al. Atrial fibrillation and sleep-disordered breathing. J Thorac Dis. 2015;7(12):E575–584. Doi: 10.3978/j.issn.2072-1439.2015.12.57.

17. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. Doi: 10.1093/eurheartj/ehw210.

18. Lavergne F, Morin L, Armitstead J, Benjafield A, Woehrle H. Atrial fibrillation and sleep-disordered breathing. 2015.

19. Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 200;49(5):565–571. Doi: 10.1016/j.jacc.2006.08.060.

20. Mooe T, Gullsby S, Rabben T, Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis. 1996;7(6):475–478.

21. Kanagala R, Murali NS, Friedman PS, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589–2594. Doi: 10.1161/01.CIR.0000068337.25994.21.

22. Neilan TG, Farhad H, Dodson JA, et al. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc. 2013;2:e000421. Doi: 10.1161/JAHA.113.000421.

23. Li L, Wang ZW, Li J, et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace. 2014;16(9):1309–1314. Doi: 10.1093/europace/euu066.

24. Linz D, Mahfoud F, Schotten U, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60(1):172–178. Doi: 10.1161/HYPERTENSIONAHA.112.191965.

25. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Longterm cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;335(9464):1046–1053. Doi: 10.1016/S0140-6736(05)71141-7.

26. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352(12):1206–1214. Doi: 10.1056/NEJMoa041832.

27. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31(8):1071–1078.

28. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008;31(8):1079–1085.

29. Rich J, Raviv A, Raviv N, Brietzke SE. All-cause mortality and obstructive sleep apnea severity revisited. Otolaryngol Head Neck Surg. 2012;147(3):583–587. Doi: 10.1177/0194599812450256.

For citation

Tyurin V.P., Savchuk О.V., Proskurnova V.V., Dobrikov E.A., Kulagina A.M. Obstructive sleep apnea as an independent predictor of cardiovascular mortality. Bulletin of Pirogov National Medical & Surgical Center. 2020;15(2):126-128. (In Russ.) https://doi.org/10.25881/BPNMSC.2020.95.30.022